These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8226747)

  • 1. Regulation of thymidine kinase and thymidylate synthase in intact human lymphoblast CCRF-CEM cells.
    Xu YZ; Plunkett W
    J Biol Chem; 1993 Oct; 268(30):22363-8. PubMed ID: 8226747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro.
    Yalowich JC; Kalman TI
    Biochem Pharmacol; 1985 Jul; 34(13):2319-24. PubMed ID: 3160352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells.
    Balzarini J; De Clercq E
    Biochim Biophys Acta; 1984 Feb; 785(1-2):36-45. PubMed ID: 6696920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line.
    Balzarini J; De Clercq E; Ayusawa D; Seno T
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA.
    Balzarini J; De Clercq E; Ayusawa D; Seno T
    Biochem J; 1984 Jan; 217(1):245-52. PubMed ID: 6696722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
    Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M
    Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of cytostatic action of novel 5-(thien-2-yl)- and 5-(furan-2-yl)-substituted pyrimidine nucleoside analogues against tumor cells transfected by the thymidine kinase gene of herpes simplex virus.
    Bohman C; Balzarini J; Wigerinck P; Van Aerschot A; Herdewijn P; De Clercq E
    J Biol Chem; 1994 Mar; 269(11):8036-43. PubMed ID: 8132526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogs.
    Voeller DM; Grem JL; Pommier Y; Paull K; Allegra CJ
    Cancer Chemother Pharmacol; 2000; 45(5):409-16. PubMed ID: 10803925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.
    Wang LM; White JC; Capizzi RL
    Cancer Chemother Pharmacol; 1990; 25(6):418-24. PubMed ID: 2311169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
    Balzarini J; De Clercq E
    Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidylate synthase inhibition in cells with arrested DNA synthesis is not due to an allosteric interaction in the replitase complex.
    Rode W; Jastreboff MM; Bertino JR
    Biochem Biophys Res Commun; 1985 Apr; 128(1):345-51. PubMed ID: 3921023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible permeabilization of lymphocytes destroys the incorporation of deoxythymidine but not of deoxycytidine.
    Taljanidisz J; Sasvari-Szekely M; Spasokutotskaja T; Antoni F; Staub M
    Biochim Biophys Acta; 1986 Mar; 885(3):266-71. PubMed ID: 3947681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of thymidylate synthase by hydroxyurea in rapidly proliferating P815 mastocytoma cells.
    Boehm TL; Kreis W; Drahovsky D
    Biochim Biophys Acta; 1982 Jan; 696(1):52-6. PubMed ID: 6805512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of a substrate cycle between thymidine and thymidylate in the regulation of DNA precursor pool in ehrlich ascites tumour.
    He Q; Skog S
    Cell Physiol Biochem; 2002; 12(5-6):305-14. PubMed ID: 12438766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine.
    Ross DD; Cuddy DP; Cohen N; Hensley DR
    Cancer Chemother Pharmacol; 1992; 31(1):61-70. PubMed ID: 1458561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of thymidine kinase activity compensates for loss of thymidylate synthase activity in Mycoplasma pneumoniae.
    Wang L; Hames C; Schmidl SR; Stülke J
    Mol Microbiol; 2010 Sep; 77(6):1502-11. PubMed ID: 20860090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of thymidylate synthetase in mouse leukemia cells (L1210).
    Rode W; Scanlon KJ; Moroson BA; Bertino JR
    J Biol Chem; 1980 Feb; 255(4):1305-11. PubMed ID: 6965493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S; Bhalla K; McCrady C
    Leuk Res; 1991; 15(4):205-13. PubMed ID: 2030601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
    Chou TC; Lopez C; Colacino JM; Feinberg A; Watanabe KA; Fox JJ; Philips FS
    Mol Pharmacol; 1984 Nov; 26(3):587-93. PubMed ID: 6092904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.